Related Experiment Video
Updated: Aug 5, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Two Cases of Lung Cancer-Associated Horner Syndrome With Divergent Outcomes Following Radiotherapy
Takuya Sasaki1, Yojiro Ishikawa2, Satoshi Teramura2
1Medical Education, Tohoku Medical and Pharmaceutical University, Sendai, JPN.
Cureus
|July 31, 2026
Summary
Horner syndrome in lung cancer patients can have varied outcomes after radiotherapy. Pre-treatment imaging showing tumor-nerve proximity may predict reversibility of this neurological condition.
Area of Science:
- Neurology
- Oncology
- Radiotherapy
Background:
- Horner syndrome is a known complication of sympathetic pathway disruption in lung cancer.
- Its reversibility after treatment is variable and difficult to predict.
